This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
Should You Buy Danaher (DHR) Ahead of Earnings?
by Zacks Equity Research
Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Can Danaher (DHR) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3M (MMM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
3M (MMM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Danaher (DHR) Stock Moves -1.38%: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $253.71, marking a -1.38% move from the previous day.
Will Cost Woes be a Spoiler for Danaher's (DHR) Q3 Earnings?
by Zacks Equity Research
High raw material costs and supply chain disruptions are likely to have hurt Danaher's (DHR) Q3 earnings. However, the top line is expected to have benefited from strong segmental performances.
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $251.68 in the latest trading session, marking a -0.97% move from the prior day.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $282.29, marking a +1.16% move from the previous day.
Key Reasons to Retain Danaher (DHR) Stock in Your Portfolio
by Zacks Equity Research
Healthy bioprocessing and consumables business bode well for Danaher (DHR). The company's shareholder friendly policies add to its attractiveness.
Danaher (DHR) Stock Moves -0.98%: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $262.66, marking a -0.98% move from the previous day.
The Zacks Analyst Blog Highlights Microsoft, Danaher, Raytheon Technologies, Stryker Corporation and Vale
by Zacks Equity Research
Microsoft, Danaher, Raytheon Technologies, Stryker Corporation and Vale are included in this Analyst Blog.
Top Stock Reports for Microsoft, Danaher & Raytheon Technologies
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Danaher Corporation (DHR) and Raytheon Technologies Corporation (RTX).
Danaher (DHR) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $278.94 in the latest trading session, marking a +0.68% move from the prior day.
Danaher (DHR) to Spin-Off Environmental Unit, Shares Pop
by Zacks Equity Research
The spin-off of the Environmental & Applied Solutions segment into a new public company should help Danaher (DHR) focus on its Life Sciences and Diagnostics segments.
Danaher (DHR) Stock Moves 1.06%: What You Should Know
by Zacks Equity Research
In the latest trading session, Danaher (DHR) closed at $293.51, marking a +1.06% move from the previous day.
Danaher (DHR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed at $272.48 in the latest trading session, marking a +1.14% move from the prior day.
Danaher (DHR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Danaher (DHR) closed the most recent trading day at $276.69, moving -1.3% from the previous trading session.
Here's Why Investors Should Retain Danaher (DHR) Stock for Now
by Zacks Equity Research
Danaher (DHR) is benefiting from strength in its Life Sciences segment, acquisitions and shareholder-friendly actions despite supply-chain challenges and escalating costs.
The Zacks Analyst Blog Highlights Alphabet, Danaher, Wells Fargo, United Parcel Service and Equinor
by Zacks Equity Research
Alphabet, Danaher, Wells Fargo, United Parcel Service and Equinor are included in this Analyst Blog.
Top Research Reports for Alphabet, Danaher & Wells Fargo
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Danaher Corporation (DHR) and Wells Fargo & Company (WFC).
Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?
by Zacks Equity Research
Sector ETF report for PTH
The Zacks Analyst Blog Highlights Broadcom, Oracle, Danaher, Deere and Northrop Grumman
by Zacks Equity Research
Broadcom, Oracle, Danaher, Deere and Northrop Grumman are included in this Analyst Blog.
Q2 Earnings Season Scorecard and Analyst Reports for Broadcom, Oracle, & Danaher
by Sheraz Mian
Today's Research Daily features a real-time update on the Q2 earnings season and new research reports on Broadcom (AVGO), Oracle (ORCL), and Danaher (DHR).
Danaher's (DHR) Q2 Earnings & Revenues Beat, Increase Y/Y
by Zacks Equity Research
Danaher's (DHR) second-quarter 2022 revenues increase 7.4% year over year, driven by an impressive performance across its segments.
Danaher (DHR) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 17.45% and 6.35%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate 3M (MMM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
3M (MMM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.